Aphria and Tilray are together at last
The company said it sold 6,901 kilograms of cannabis in the fourth quarter
Aphria and Tilray combine with a pro forma revenue of C$874 million
The trial will now move to a larger phase
Products “had significantly lower THC or CBD than they led them to believe”
The so-called verified stockholder derivative suit was filed by shareholder Lee Morgan
Consumers stocked up at end of March, but the surge likely didn’t continue
The revenue miss was mostly due to a decline in bulk sales
Tilray has suffered from lower-than-expected revenues amid an oversupplied market
The study could provide scientists with more clinical evidence on CBD